Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A diffuse large B-cell lymphoma primarily involving the thyroid gland.
Biomarker and diagnostic research for thyroid gland diffuse large B-cell lymphoma has been reported in the published literature.
No clinical trials have been registered for thyroid gland diffuse large B-cell lymphoma.
71 publications have been identified in PubMed for thyroid gland diffuse large B-cell lymphoma. Research spans Case Report / Case Series (45%), Basic Science / Preclinical (14%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 32 | 45% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 1:59 AM UTC
Laboratory research
10 |
14% |
Disease patterns and progression | 10 | 14% |
Testing and diagnosis research | 9 | 13% |
Clinical study results | 5 | 7% |
Research summaries | 4 | 6% |
New treatment approaches | 1 | 1% |
Tatoğlu MT (2026). [PMID: 41663627](https://pubmed.ncbi.nlm.nih.gov/41663627/). *Journal of ultrasound*. [Case Report / Case Series]
Sengul I (2026). [PMID: 41797754](https://pubmed.ncbi.nlm.nih.gov/41797754/). *Clinical case reports*. [Diagnostic / Biomarker]
Daoudi C (2026). [PMID: 41853428](https://pubmed.ncbi.nlm.nih.gov/41853428/). *Cureus*. [Case Report / Case Series]
Döger FK (2026). [PMID: 42072794](https://pubmed.ncbi.nlm.nih.gov/42072794/). *Diagnostics (Basel)*. [Epidemiology / Natural History]
Eletrebi M (2026). [PMID: 42011749](https://pubmed.ncbi.nlm.nih.gov/42011749/). *Int J Gynecol Pathol*. [Case Report / Case Series]
Nath AR (2026). [PMID: 41090618](https://pubmed.ncbi.nlm.nih.gov/41090618/). *Diagnostic cytopathology*. [Case Report / Case Series]
Ibrahim EA (2026). [PMID: 41712976](https://pubmed.ncbi.nlm.nih.gov/41712976/). *Journal of medical imaging and radiation sciences*. [Review / Meta-Analysis]
Sayes MF (2026). [PMID: 41930191](https://pubmed.ncbi.nlm.nih.gov/41930191/). *Frontiers in oncology*. [Case Report / Case Series]
Zhao JL (2026). [PMID: 41676201](https://pubmed.ncbi.nlm.nih.gov/41676201/). *AME case reports*. [Case Report / Case Series]
Hu Z (2026). [PMID: 41795121](https://pubmed.ncbi.nlm.nih.gov/41795121/). *Journal of medical case reports*. [Case Report / Case Series]
AI-curated news mentioning thyroid gland diffuse large B-cell lymphoma
Updated Sep 16, 2026
A recent study analyzes prognostic factors and survival rates in HHV8 positive diffuse large B cell lymphoma using national cancer database data. The findings may inform treatment strategies and patient management for this rare lymphoma subtype.
A recent study highlights hemophagocytic lymphohistiocytosis as a potential initial presentation of occult diffuse large B-cell lymphoma, posing significant diagnostic challenges. This finding underscores the need for heightened awareness among clinicians to improve early detection and treatment outcomes.
A recent study highlights a rare presentation of diffuse large B-cell lymphoma, where peritoneal lymphomatosis can mimic complicated hydatid cysts on imaging. This finding emphasizes the need for careful differential diagnosis in similar cases.
ADC Therapeutics faces significant setbacks as its lymphoma drug Zynlonta, when combined with rituximab, resulted in 27 patient deaths and showed no overall survival benefit in diffuse large B cell lymphoma. This raises concerns about its viability as a second-line treatment.